| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/06/1996 | EP0699091A1 Method and device for the production of a transdermal therapeutic system |
| 03/06/1996 | EP0699068A1 Reduction of liposome-induced adverse physiological reactions |
| 03/06/1996 | EP0670714A4 Retinoic acid-containing compositions. |
| 03/06/1996 | EP0643575B1 Metering spray designed for pernasal application |
| 03/06/1996 | EP0630231B1 Liposomes with excess negative charge |
| 03/06/1996 | EP0615447B1 Slow-release flurbiprofen-containing medicament and its use |
| 03/06/1996 | EP0615444B1 Peroral administration form for peptidic medicaments, in particular insulin |
| 03/06/1996 | CN1118143A Excipient stabilization of polypeptides treated with organic solvents |
| 03/06/1996 | CN1118139A Fibrinogen receptor antagonists |
| 03/06/1996 | CN1118136A Methods for in vivo delivery of biologics and compositions useful therefor |
| 03/06/1996 | CN1118001A Semi-fermented chrysanthemum wine series and processing technology thereof |
| 03/06/1996 | CN1117874A Nasally administrable compositions |
| 03/06/1996 | CN1117862A Quick-acting Yanhouning aerosol and its preparation method |
| 03/06/1996 | CN1117861A Peppermint brain-refreshment preparation |
| 03/06/1996 | CN1117849A Quick-acting contrast medium for cholecystography and cholangiography |
| 03/05/1996 | US5496846 Taxol treatment of breast cancer |
| 03/05/1996 | US5496820 Ophthalmic use of S-timolol hemihydrate |
| 03/05/1996 | US5496819 Drug delivery |
| 03/05/1996 | US5496818 Oil-in-water type; dispersed lipid phase of vegetable oil, phospholipid emulsifier and strongly basic hydrophobic pharmaceutical; aqueous phase with buffer and small amount of ionized pharmaceutical; positive charge at emulsion interface |
| 03/05/1996 | US5496813 Spontaneously dispersible concentrates and aqueous microemulsions with steryl retinates having anti-tumor activity |
| 03/05/1996 | US5496811 Submicron emulsions as ocular drug delivery vehicles |
| 03/05/1996 | US5496809 Of water, 8-n-(diethylaminoethyl)rebeccamycin and a pharmaceutically acceptable acid |
| 03/05/1996 | US5496801 Storage stability, mannitol, citric acid buffer |
| 03/05/1996 | US5496567 Vitamin supplements |
| 03/05/1996 | US5496565 Microspherules |
| 03/05/1996 | US5496564 Suspendible composition and process for preparing the same |
| 03/05/1996 | US5496563 Dry gel composition |
| 03/05/1996 | US5496561 Time-release agents for drugs from membrane layers of polymers |
| 03/05/1996 | US5496560 Administered for short-term therapy of cardiovascular and sleep disorders; side effect reduction |
| 03/05/1996 | US5496559 Porous solid formulations containing proteinaceous physiologically active substances |
| 03/05/1996 | US5496558 Solid form xerostomia product |
| 03/05/1996 | US5496557 Wall is composed of two degradable polymers, one permeable to active substance, the other poorly permeable; polymers are poly/ortho/esters, poly-alpha-amino acids, polydepsipeptides, polyanhydrides, polyphosphazenes, copolymers, stereo complexes |
| 03/05/1996 | US5496552 Osteogenic devices |
| 03/05/1996 | US5496545 Phosphate-binding polymers for oral administration |
| 03/05/1996 | US5496539 Oral compositions |
| 03/05/1996 | US5496537 General anesthetics for nasal delivery using propofol with propellants |
| 03/05/1996 | US5496535 Gas generating agent, improved palatability, magnetic resonance imaging |
| 03/05/1996 | CA2010022C Anesthetic oral compositions |
| 03/05/1996 | CA1338106C Finely divided solid crystalline powders via precipitation into an anti-solvent |
| 03/01/1996 | CA2157240A1 Pharmaceutical formulation of nizatidine |
| 02/29/1996 | WO1996005864A1 Solid pharmaceutical form for the administration of a liposoluble liquid active substance |
| 02/29/1996 | WO1996005857A1 Device for delivery of substances and methods of use thereof |
| 02/29/1996 | WO1996005843A1 Pharmaceutical compositions comprising co-dried sucralfate gel and polyalcohol |
| 02/29/1996 | WO1996005842A1 Intravenous alendronate formulations |
| 02/29/1996 | WO1996005834A1 Improved pharmaceutical formulations containing ibuprofen and codeine |
| 02/29/1996 | WO1996005821A1 Liposome-encapsulated taxol, its preparation and its use |
| 02/29/1996 | WO1996005816A1 Treatment of animals |
| 02/29/1996 | WO1996005815A1 Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives |
| 02/29/1996 | WO1996005814A1 Oestradiol transdermal therapeutic system comprising hygroscopic additives |
| 02/29/1996 | WO1996005813A1 Medical contact adhesive |
| 02/29/1996 | WO1996005812A1 Hydrophilic controlled release device |
| 02/29/1996 | WO1996005810A1 Drug delivery composition containing chitosan or derivative thereof having a defined z. potential |
| 02/29/1996 | WO1996005809A1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
| 02/29/1996 | WO1996005808A1 Unilamellar liposomal preparations with high active substance content |
| 02/29/1996 | WO1996001128A3 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets |
| 02/29/1996 | WO1996001100A3 Hydrogel for the application of therapeutic and/or cosmetic active substances to the skin |
| 02/29/1996 | DE4429791A1 Medizinischer Haftkleber Medical adhesives |
| 02/29/1996 | DE4429747A1 Cosmetic ointment and cream bases |
| 02/29/1996 | CA2198452A1 Treatment of animals |
| 02/29/1996 | CA2188948A1 Device for delivery of substances and methods of use thereof |
| 02/28/1996 | EP0698393A1 Solubilizing agent and external preparation containing the same |
| 02/28/1996 | EP0698389A1 Controlled release matrix for pharmaceuticals |
| 02/28/1996 | EP0698388A1 Ophthalmic preparation for use as artificial tear |
| 02/28/1996 | EP0697890A1 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent |
| 02/28/1996 | EP0697887A1 Stable liquid compositions of gamma interferon |
| 02/28/1996 | EP0697881A1 New cyclosporine-containing pharmaceutical compositions for oral administration |
| 02/28/1996 | EP0697869A1 Transdermal therapeutic systems for the administration of serotonin agonists |
| 02/28/1996 | EP0697867A1 Compositions in the form of solid solutions |
| 02/28/1996 | EP0697866A1 High dose formulations |
| 02/28/1996 | EP0697860A1 Transdermal therapeutic system containing estradiol |
| 02/28/1996 | EP0697859A1 Stable, ingestable and absorbable nadh and nadph therapeutic compositions |
| 02/28/1996 | EP0697858A1 Nasal drug delivery composition containing nicotine |
| 02/28/1996 | EP0697814A1 Pour-on formulations containinng polymeric material, glycols and glycerides |
| 02/28/1996 | EP0697811A1 Non-hazardous pest control |
| 02/28/1996 | EP0661966A4 Ulcer prevention and treatment composition and method. |
| 02/28/1996 | EP0630644A4 Anti-microbial and interferon-inducing pharmaceutical compound. |
| 02/28/1996 | EP0588897B1 Non-chlorofluorocarbon aerosol formulations |
| 02/28/1996 | EP0533836B1 Reversible gelation compositions and methods of use |
| 02/28/1996 | EP0525105B1 Polyisobutylene adhesives for transdermal devices |
| 02/28/1996 | EP0362367B1 Osteogenic devices |
| 02/28/1996 | CN2220864Y "Haian" bougie for treatment of asthma |
| 02/28/1996 | CN1117394A External adhesive plaster for curing infantile pneumonia |
| 02/28/1996 | CN1117392A Anti-wart liniment |
| 02/28/1996 | CN1117388A Compound bupleuri liniment |
| 02/28/1996 | CN1117385A Medicinal granules for treating pediatric anorexia |
| 02/28/1996 | CN1117383A Cefixime composition |
| 02/28/1996 | CN1117381A Medicinal prepn. for treating ringworm |
| 02/28/1996 | CN1117380A Aerosol for treating heart disease |
| 02/28/1996 | CN1117351A Formulation and methods of treatment |
| 02/28/1996 | CN1117348A Health-care tea containing euphorbia helioscopia L., method and prescription for mfg. same |
| 02/27/1996 | WO1996006602A1 COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF |
| 02/27/1996 | USRE35162 Rumen and other stomach chamber bypass nutrients and methods of fabrication |
| 02/27/1996 | US5494938 Comprisinga water insoluable oil, alkyl glucosides and fatty acid glycerides; storage stability, homogeneity |
| 02/27/1996 | US5494901 Includes carbonic anhydrase inhibitor |
| 02/27/1996 | US5494683 Surface modified anticancer nanoparticles |
| 02/27/1996 | US5494682 Encapsulated biomass in crosslinked polymer material |
| 02/27/1996 | US5494681 Molten blend of active material, spatially oriented matrix comprising wax core material, hydrophobic polymer |
| 02/27/1996 | US5494680 Transdermal delivery device |
| 02/27/1996 | US5494679 Molecules for iontophoretic delivery |
| 02/27/1996 | US5494677 Tissue-specific implantable therapeutic agent delivery system |